KRT4 anticorps (C-Term)
Aperçu rapide pour KRT4 anticorps (C-Term) (ABIN453162)
Antigène
Voir toutes KRT4 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- This antibody reacts to Cytokeratin-4 (KRT4).
-
Purification
- Saturated Ammonium Sulfate (SAS) precipitation
-
Immunogène
- KLH conjugated synthetic peptide selected from the C-terminal region of human KRT4
-
-
-
-
Indications d'application
-
ELISA: 1/1,000. Western blotting: 1/50 - 1/100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- KRT4 (Keratin 4 (KRT4))
-
Autre désignation
- Cytokeratin 4
-
Sujet
- The protein is a member of the keratin family. The type II cytokeratins consist of basic or neutral proteins which are arranged in pairs of heterotypic keratin chains coexpressed during differentiation of simple and stratified epithelial tissues. This type II cytokeratin is specifically expressed in differentiated layers of the mucosal and esophageal epithelia with family member KRT13.Synonyms: CK4, CYK4, Cytokeratin-4, K4, KRT4, Keratin, Keratin-4, type II cytoskeletal 4
-
ID gène
- 3851
-
NCBI Accession
- NP_002263
-
UniProt
- P19013
Antigène
-